Dientamoeba fragilis laboratory diagnosis

Diagnostic challenges

The difficulty involved in microscopically diagnosing D. fragilis in feces has led to the development of real-time PCR methodologies for the detection of D. fragilis in stool samples. Genetic Signatures' EasyScreen Gastrointestinal Parasite Detection Kit and GS1 automated workflow can detect D. fragilis, and 7 other leading parasites, in a single test.

This solution has received FDA (510k) clearance for sales in the United States.

See below for details.

Traditional O&P examinations / microscopy

Diagnosis of D. fragilis has traditionally relied upon microscopy of fixed faecal smears. Because of the “fragile” nature of the organism, prompt fixation of clinical specimens is essential as the trophozoites degenerate rapidly once passed in stool samples.

The trophozoite stage of the parasite is not usually detectable if stool concentration methods are used. In addition, D. fragilis trophozoites can easily be overlooked or misidentified because they are pale-staining and their nuclei sometimes resemble those of Endolimax nana or Entamoeba hartmanni.

The trophozoites are also highly pleomorphic, with many variations in shape and size making diagnosis by microscopy difficult. It is almost impossible to identify this parasite using a wet mount microscopic exam, thus, a permanent stain is mandatory.

Dientamoeba-fragilis-Parasite-stain

Fecal immunoassays

No immunoassays are commercially available.

*Image credit: CDC website - www.cdc.gov/dpdx/dientamoeba

Molecular methods for detecting D. fragilis

Currently, Genetic Signatures EasyScreen Gastrointestinal Detection Kit is the only FDA (510k) cleared molecular diagnostic solution available that can detect Dientamoeba fragilis, together with 7 other leading gastrointestinal parasites, in a single test.

Syndromic testing for gastrointestinal parasites also supports the identification of unsuspected cases or undiagnosed cases. This is particularly important for patients with variable symptoms.

Screening of donor fecal microbiota transplantation using a molecular parasite panel would ensure that asymptomatic gastrointestinal parasite infections are detected.

Syndromic testing for 8 gastrointestinal parasites in a single test

Up to 60 patients screened in a single, automated workflow...with same day reporting!

Genetic Signatures Syndromic workflow for detecting gastrointestinal parasites

Find out more about our unique 3base™ solution for detecting gastrointestinal parasites

3base™ advantage for parasite testing

The benefits of employing 3base™ technology for multiplex real-time PCR detection of gastrointestinal parasites

Webinars, blogs, podcasts

Leading parasitologists speak to the challenges of detecting GI parasites and the benefits of molecular testing

White papers, publications

Clinical evidence supporting the benefits of molecular testing for gastrointestinal parasites

Case studies & testimonials

Learn what industry leaders think of Genetic Signatures' novel solution for GI parasite detection

Clinically important parasites

An overview of the leading gastrointestinal parasites: Symptoms, diagnosis and treatment

References